Description
The recombinant human c-Met-resistant antibody has the advantages that can be specifically combined with human c-Met, combination of HGF (hepatocyte growth factors) and the human c-Met can be blocked, HGF/c-Met signal transduction pathways can be screened and blocked, and accordingly important effects can be realized by the antibody in the aspect of research and development of neutralization antibody medicines for suppressing tumor growth.
Target
MET
Target Alias Names
HGFR, AUTS9, RCCP2, c-Met, DFNB97
Isotype/Mimetic
Human IgG1
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression